Entering text into the input field will update the search result below

Johnson & Johnson reportedly shopping its blood-testing division

Sep. 06, 2013 1:55 PM ETJohnson & Johnson (JNJ) StockJNJBy: David Yelle, SA News Editor6 Comments
  • Johnson & Johnson (JNJ +0.7%) is making the rounds to companies that might be interested in buying its blood-testing division, which could fetch around $5B.
  • JNJ's Ortho Clinical Diagnostics unit makes tests that can reveal a patient's blood type and screen for viruses like HIV and hepatitis C. It also makes tests that help diagnose a heart attack and assess damage to the heart.
  • The testing business is part of a $46B world-wide market for in vitro diagnostics that is growing 6% - 7% a year.
  • A potential deal could be wrapped up by as early as the year's end.

Recommended For You

About JNJ Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
JNJ--
Johnson & Johnson
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.